RespRate, a device that guides users to breathe at five breaths per minute, was cleared by the FDA as an adjunct treatment for hypertension following clinical trials showing consistent reductions in blood pressure. The FDA approval makes device-guided slow breathing one of the few non-pharmacological interventions for hypertension that has cleared the same regulatory bar as drugs. The mechanism is understood, the evidence is consistent, and the intervention costs nothing beyond the time required to practise it.
The Baroreflex Mechanism
The arterial baroreflex is the body's primary short-term blood pressure regulator. Baroreceptors in the aortic arch and carotid sinuses detect pressure changes and signal the brainstem to adjust heart rate and vascular tone. The baroreflex operates at a characteristic frequency of approximately 0.1 Hz, which corresponds to a breathing rate of exactly six breaths per minute. Breathing at this resonance frequency synchronises the baroreflex with the respiratory cycle, amplifying its regulatory efficiency and producing sustained reductions in sympathetic vascular tone. Over time, this appears to produce durable reductions in baseline blood pressure beyond the immediate session effects.
Trial Evidence
A meta-analysis by Oneda et al. of slow breathing interventions for hypertension found average reductions of 7.5mmHg systolic and 4.5mmHg diastolic in adults with stage 1 or 2 hypertension. Individual trials have shown reductions up to 10mmHg systolic with 15 minutes of daily practice over eight weeks. These are clinically significant reductions: a 10mmHg reduction in systolic blood pressure is associated with approximately 20 percent reduction in stroke risk and 17 percent reduction in cardiovascular mortality in epidemiological data.
Practical Protocol
The protocol studied in most trials involves 15 minutes of slow breathing daily at five to six breaths per minute, with inhalation and exhalation of equal or near-equal length. A simple count of five in and five out through the nose, sustained for 15 minutes, approximates the resonance frequency breathing studied in clinical trials without requiring a device. Blood pressure reductions are typically detectable after four weeks of consistent practice and continue to improve to approximately eight weeks.
- Practise 15 minutes of slow breathing at five to six breaths per minute daily
- Measure blood pressure before and after your session: acute reductions confirm you are achieving the resonance effect
- Morning practice may produce sustained daytime blood pressure reductions in hypertensive adults
- Do not discontinue antihypertensive medication without medical review: breathing practice is an adjunct, not a replacement
- After eight weeks, seek a blood pressure review with your GP to reassess medication need
Sources
- Oneda, B., et al. (2010). Sympathetic nerve activity is decreased during device-guided slow breathing. Hypertension Research, 33(7), 708-712.
- Grossman, E., et al. (2001). Breathing-control lowers blood pressure. Journal of Human Hypertension, 15(4), 263-269.
- Brook, R.D., et al. (2013). Beyond medications and diet: alternative approaches to lowering blood pressure. Hypertension, 61(6), 1360-1383.